SCHEMBL7002495

SCHEMBL7002495

N[C@@H]1CC1c1ccccc1Cl

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.66
HTR2C P28335 2/20 0.58
HTR2A P28223 1/20 0.58
HTR2B P41595 1/20 0.58
KDM1A O60341 13/20 0.57
KDM1B Q8NB78 3/20 0.57
SLC9A1 P19634 1/20 0.49
MAOA P21397 7/20 0.48
MAOB P27338 7/20 0.48
CYP2C19 P33261 4/20 0.48
CYP2B6 P20813 3/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
TAAR1 Q96RJ0 2/20 0.48
LMNA P02545 1/20 0.48
CYP3A4 P08684 1/20 0.48
HTR1A P08908 1/20 0.48
ADRA2A P08913 1/20 0.48
CYP2A6 P11509 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8144697 1.00 DPP4 (0.66) DPP4HTR2CHTR2AHTR2BKDM1A
SCHEMBL30052677 1.00 DPP4 (0.66) DPP4HTR2CHTR2AHTR2BKDM1A
SCHEMBL15542134 1.00 DPP4 (0.66) DPP4HTR2CHTR2AHTR2BKDM1A
SCHEMBL8144699 1.00 DPP4 (0.66) DPP4HTR2CHTR2AHTR2BKDM1A
SCHEMBL31508220 1.00 DPP4 (0.66) DPP4HTR2CHTR2AHTR2BKDM1A
SCHEMBL29546108 1.00 DPP4 (0.66) DPP4HTR2CHTR2AHTR2BKDM1A
SCHEMBL7002501 1.00 DPP4 (0.66) DPP4HTR2CHTR2AHTR2BKDM1A
Hydrochloric Acid SCHEMBL15541881 0.98 DPP4 (0.63) DPP4HTR2CHTR2AHTR2BKDM1A
Hydrochloric Acid SCHEMBL15541879 0.98 DPP4 (0.63) DPP4HTR2CHTR2AHTR2BKDM1A
Trifluoroacetic Acid SCHEMBL15541005 0.83 DPP4 (0.49) DPP4HTR2CHTR2AHTR2BKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996621-B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS ASTRAZENECA AB (SE) 2003-10-01 EP disclosed
US-6251910-B1 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists ASTRAZENECA UK LIMITED (GB) 2001-06-26 US disclosed